The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Prevention of thrombocytopenia using thrombopoietin in high-dose cytarabine treatment of non-Hodgkin lymphoma.
He Huang
No relevant relationships to disclose
Zhao Wang
No relevant relationships to disclose
Huangming Hong
No relevant relationships to disclose
Chengcheng Guo
No relevant relationships to disclose
Xueying Li
No relevant relationships to disclose
Mengping Zhang
No relevant relationships to disclose
Xiaoting Lin
No relevant relationships to disclose
Xiaojie Fang
No relevant relationships to disclose
Xiaohong Fu
No relevant relationships to disclose
Ying Tian
No relevant relationships to disclose
Shanshan Li
No relevant relationships to disclose
Tingzhi Liu
No relevant relationships to disclose
Chaoyong Liang
No relevant relationships to disclose
Jia Tian Lin
No relevant relationships to disclose
Dr.Prem Raj Shrestha
No relevant relationships to disclose
Jian Xiao
No relevant relationships to disclose
Hongyu Zhang
No relevant relationships to disclose
Yabing Cao
No relevant relationships to disclose
Linzhu Zhai
No relevant relationships to disclose
Tongyu Lin
No relevant relationships to disclose